Efficacy and feasibility of isometric arm counter-pressure manoeuvres to abort impending vasovagal syncope during real life.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 15172651)

Published in Europace on July 01, 2004

Authors

Francesco Croci1, Michele Brignole, Carlo Menozzi, Alberto Solano, Paolo Donateo, Daniele Oddone, Enrico Puggioni, Gino Lolli

Author Affiliations

1: Arrhythmologic Centre, Department of Cardiology, Ospedali del Tigullio, Via don Bobbio, 16033 Lavagna, Italy.

Articles citing this

Association between psychological complaints and recurrence of vasovagal syncope. Clin Auton Res (2011) 0.75

Articles by these authors

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail (2012) 10.38

Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J (2009) 8.25

Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach. N Engl J Med (2004) 4.19

2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace (2013) 4.07

Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation (2012) 2.53

Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial). J Am Coll Cardiol (2006) 2.33

Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07. Europace (2009) 2.33

Indications for the use of diagnostic implantable and external ECG loop recorders. Europace (2009) 2.06

Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. Eur Heart J (2004) 2.01

A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. Eur Heart J (2009) 1.89

A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J (2005) 1.84

Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. Eur Heart J (2011) 1.64

Additional diagnostic value of very prolonged observation by implantable loop recorder in patients with unexplained syncope. J Cardiovasc Electrophysiol (2011) 1.61

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Rev Esp Cardiol (Engl Ed) (2014) 1.61

Syncope due to idiopathic paroxysmal atrioventricular block: long-term follow-up of a distinct form of atrioventricular block. J Am Coll Cardiol (2011) 1.56

Acute comparative effect of right and left ventricular pacing in patients with permanent atrial fibrillation. J Am Coll Cardiol (2004) 1.56

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Heart Rhythm (2012) 1.54

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace (2012) 1.46

Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J (2006) 1.43

Restoring sinus rhythm results in blood pressure reduction in patients with persistent atrial fibrillation and a history of hypertension. J Cardiovasc Electrophysiol (2012) 1.43

Early and late outcome of treated patients referred for syncope to emergency department: the EGSYS 2 follow-up study. Eur Heart J (2010) 1.31

A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J (2004) 1.31

Benefit of pacemaker therapy in patients with presumed neurally mediated syncope and documented asystole is greater when tilt test is negative: an analysis from the third International Study on Syncope of Uncertain Etiology (ISSUE-3). Circ Arrhythm Electrophysiol (2013) 1.28

Simultaneous dual fast and slow pathway conduction upon induction of typical atrioventricular nodal reentrant tachycardia: electrophysiologic characteristics in a series of patients. J Cardiovasc Electrophysiol (2005) 1.23

Recurrent unexplained palpitations (RUP) study comparison of implantable loop recorder versus conventional diagnostic strategy. J Am Coll Cardiol (2007) 1.15

Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation (2002) 1.11

Proposed electrocardiographic classification of spontaneous syncope documented by an implantable loop recorder. Europace (2005) 1.08

Are complications of implantable defibrillators under-estimated and benefits over-estimated? Europace (2009) 1.05

Effects of right ventricular pacing on intra-left ventricular electromechanical activation in patients with native narrow QRS. Am J Cardiol (2006) 1.00

Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope. Eur Heart J (2006) 0.99

The prevalence and cost of the faint and fall problem in the state of Utah. Pacing Clin Electrophysiol (2010) 0.98

Incidence, diagnostic yield and safety of the implantable loop-recorder to detect the mechanism of syncope in patients with and without structural heart disease. Eur Heart J (2004) 0.95

Left ventricular mechanics during right ventricular apical or left ventricular-based pacing in patients with chronic atrial fibrillation after atrioventricular junction ablation. J Am Coll Cardiol (2004) 0.95

Cardioinhibitory carotid sinus hypersensitivity predicts an asystolic mechanism of spontaneous neurally mediated syncope. Europace (2007) 0.95

Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly persons: a randomized single-blind controlled study. J Am Coll Cardiol (2006) 0.94

Results and complications of the carotid sinus massage performed according to the "method of symptoms". Am J Cardiol (2002) 0.94

Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study. Europace (2004) 0.93

Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol (2002) 0.92

The pectoralis major tendon as a reference for restoring humeral length and retroversion with hemiarthroplasty for fracture. J Shoulder Elbow Surg (2008) 0.92

Is vasovagal syncope a disease? Europace (2007) 0.92

Orthostatic hypotension as cause of syncope in patients older than 65 years admitted to emergency departments for transient loss of consciousness. J Gerontol A Biol Sci Med Sci (2009) 0.91

Reproducibility of electrocardiographic findings in patients with suspected reflex neurally-mediated syncope. Am J Cardiol (2008) 0.90

Relation of clinical presentation of syncope to the age of patients. Am J Cardiol (2005) 0.90

Vagally mediated atrioventricular block: pathophysiology and diagnosis. Heart (2013) 0.90

Consensus document on antithrombotic therapy in the setting of electrophysiological procedures. Europace (2008) 0.89

Syncope in the emergency department: comparison of standardized admission criteria with clinical practice. Europace (2011) 0.89

Key challenges in the current management of syncope. Nat Rev Cardiol (2012) 0.87

The usage and diagnostic yield of the implantable loop-recorder in detection of the mechanism of syncope and in guiding effective antiarrhythmic therapy in older people. Europace (2005) 0.85

Left ventricular electromechanical delay in patients with heart failure and normal QRS duration and in patients with right and left bundle branch block. Europace (2007) 0.85

Symptom onset-to-balloon time and mortality in the first seven years after STEMI treated with primary percutaneous coronary intervention. Heart (2012) 0.84

Diagnosis of neurally mediated syncope at initial evaluation and with tilt table testing compared with that revealed by prolonged ECG monitoring. An analysis from the Third International Study on Syncope of Uncertain Etiology (ISSUE-3). Heart (2013) 0.84

Acute ischemic stroke in anterior choroidal artery territory. J Neurol Sci (2009) 0.84

Syncope Unit: rationale and requirement - the European Heart Rhythm Association position statement endorsed by the Heart Rhythm Society. Europace (2015) 0.84

Cadaveric and three-dimensional computed tomography study of the morphology of the scapula with reference to reversed shoulder prosthesis. J Orthop Surg Res (2008) 0.83

Syncope without prodromes in patients with normal heart and normal electrocardiogram: a distinct entity. J Am Coll Cardiol (2013) 0.83

Standardized care pathway versus conventional approach in the management of patients presenting with faint at the University of Utah. Pacing Clin Electrophysiol (2012) 0.83

The history of diagnosing carotid sinus hypersensitivity: why are the current criteria too sensitive? Europace (2010) 0.82

Discrepancy between clinical practice and standardized indications for an implantable loop recorder in patients with unexplained syncope. Europace (2010) 0.82

The natural history of carotid sinus syncope and the effect of cardiac pacing. Europace (2011) 0.82

Mechanism of syncope in patients with positive adenosine triphosphate tests. J Am Coll Cardiol (2003) 0.81

Vasovagal syncope and vasovagal disease. Hellenic J Cardiol (2008) 0.81

Early EPS/ICD strategy in survivors of acute myocardial infarction with severe left ventricular dysfunction on optimal beta-blocker treatment. The BEta-blocker STrategy plus ICD trial. Europace (2005) 0.81